AtaiBeckley (ATAI) traded 119.8 million shares against a thirty-day average of 8.4 million shares — 14.2 times its own norm, or $872m changing hands. The price fell 1.5% to $7.28.
That leaves the price near the top of its twelve-month band of $3.35 to $7.44 — 96% of the way up it. The peak itself came 10 sessions ago on August 25, 2026, while the floor dates back to March 27, 2026, 117 sessions ago.
The stock is down 0.8% over five sessions, up 0.4% over a month, up 49.2% over the year. The week and the year point in opposite directions. It closed below its thirty-day average price by 0.0%.
High to low, the session covered 2.3% of price — well beyond the 0.8% this stock averages over thirty sessions. The close gave most of it back, settling only 29% up the day's range.
Worth $3bn, the company sits 124 of 128 by size within healthcare. The sector as a whole finished -2.3%, leaning the same way.
Trading opened at $7.32, touched $7.40 at best and $7.23 at worst, and finished on $7.28 — 2.2% short of the $7.44 annual peak, 117.3% clear of the $3.35 annual floor.
Turnover of $872m compares with $62m on an average session for this stock, so participation was well above its own norm. Against the year, today ranks between the +33.4% best and the -15.2% worst day.
Recent form leans positive: 12 of the last thirty sessions closed up against 9 down. Its strongest single day in the past year was +33.4% on July 16, 2026, its weakest -15.2% on November 5, 2025.
The nearest names by size in the same sector went the same way: Supernus Pharmaceuticals (SUPN) -2.5% and CareDx (CDNA) -1.1%. On money traded ATAI placed 129th of 986 that session.
This text was generated automatically from the closing data. It contains no forecasts and no investment advice — only what the numbers say. Do your own research.